Jennifer Conley
Family Medicine · Nevada, MONPI 1194720862
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $666 and has fallen 55.9% since, to $294 in 2025.
Across 67 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$281
- Amgen$144
- Medline Industries LP$103
- AbbVie$84
- Axsome Therapeutics, Inc.$74
- GSK$61
- plus $572 from 21 others
What the payments were for
- Food & beverage$1,313100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $281 |
| Amgen | 8 | $144 |
| Medline Industries LP | 2 | $103 |
| AbbVie | 5 | $84 |
| Axsome Therapeutics, Inc. | 5 | $74 |
| GSK | 3 | $61 |
| Pfizer | 4 | $61 |
| Organon | 3 | $51 |
| Avanir Pharmaceuticals, Inc. | 2 | $48 |
| Novo Nordisk | 3 | $47 |
| Johnson & Johnson | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Boehringer Ingelheim | 2 | $29 |
| Lundbeck LLC | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Exeltis, USA Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Merck | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
| Sage Therapeutics, LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
| Novartis | 1 | $12 |
| Mylan Specialty L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$117
How this compares
$1,319 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 79 | $42,830 |
| MounjaroTirzepatide | 22 | $23,374 |
| JardianceEmpagliflozin | 36 | $22,215 |
| OzempicSemaglutide | 16 | $21,218 |
| JanuviaSitagliptin Phosphate | 30 | $17,067 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 20 | $13,631 |
| XareltoRivaroxaban | 24 | $13,004 |
| TrulicityDulaglutide | 12 | $12,705 |
| FarxigaDapagliflozin Propanediol | 19 | $12,436 |
| PremarinEstrogens, Conjugated | 11 | $5,754 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 17 | $5,697 |
| Levemir FlexpenInsulin Detemir | 23 | $5,625 |
| BrilintaTicagrelor | 12 | $5,436 |
| Duloxetine Hcl | 67 | $3,315 |
| Fentanyl | 23 | $3,301 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Premarin, Abrysvo | $61 | $51,346102 claims |
| Lilly USA, LLCMounjaro, Trulicity | $12 | $36,07934 claims |
| Boehringer IngelheimJardiance | $29 | $22,21536 claims |
| Novo NordiskOzempic | $47 | $21,21816 claims |
| AstraZenecaFarxiga, Brilinta | $281 | $17,87231 claims |
| MerckJanuvia | $15 | $17,06730 claims |
| Johnson & JohnsonXarelto | $36 | $13,00424 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Nevada
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.